L Puig

Summary

Affiliation: Hospital de la Santa Creu i Sant Pau
Country: Spain

Publications

  1. doi request reprint Validation of the Spanish Acne Severity Scale (Escala de Gravedad del Acné Española--EGAE)
    Lluis Puig
    Department of Dermatology, Hospital de Sant Pau, C Sant Antoni Maria Claret, 167, 08025 Barcelona, Spain
    Eur J Dermatol 23:233-40. 2013
  2. ncbi request reprint [Which patient is a candidate for treatment with efalizumab and why?]
    L Puig
    Servicio de Dermatologia, Hospital de la Santa Creu i Sant Pau, Barcelona, Espana
    Actas Dermosifiliogr 99:51-61. 2008
  3. ncbi request reprint [Infliximab: patients selection]
    L Puig
    Servicio de Dermatologia, Hospital de Santa Creu i Sant Pau, Barcelona, Espana
    Actas Dermosifiliogr 99:23-9. 2008
  4. ncbi request reprint [Efficacy of treatment with infliximab in patients with moderate-severe psoriasis and high needs of therapy. A retrospective study of 43 patients]
    L Puig
    Servicio de Dermatologia, Hospital de Santa Creu i Sant Pau, Barcelona, Espana
    Actas Dermosifiliogr 99:30-5. 2008
  5. doi request reprint [Narrowband UV-B, monochromatic excimer laser, and photodynamic therapy in psoriasis: a consensus statement of the Spanish Psoriasis Group]
    J M Carrascosa
    Servicio de Dermatologia, Hospital Universitari Germans Trias i Pujol, Universitat Autonoma de Barcelona, Espana
    Actas Dermosifiliogr 102:175-86. 2011
  6. ncbi request reprint [Consensus document on the evaluation and treatment of moderate-to-severe psoriasis. Spanish psoriasis group of the Spanish Academy of Dermatology and Venereology]
    L Puig
    Servicio de Dermatologia, Hospital de la Santa Creu i Sant Pau Barcelona, Espana
    Actas Dermosifiliogr 100:277-86. 2009
  7. doi request reprint Clinical practice guideline for an integrated approach to comorbidity in patients with psoriasis
    E Dauden
    Dermatology Department, IIS Princesa, Hospital Universitario La Princesa, Madrid, SpainRheumatology Department, IIS Princesa, Hospital Universitario La Princesa, Madrid, SpainInternal Medicine Department, IIS Princesa, Hospital Universitario La Princesa, Madrid, SpainDepartment of Psychiatry, Hospital Miguel Servet, Zaragoza, SpainAdvanced Techniques in Health Services Research TAISS, Madrid, SpainDermatology Department, Hospital Germans Trias i Pujol, Badalona, SpainDermatology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, SpainDermatology Department, Hospital General, Valencia, Spain
    J Eur Acad Dermatol Venereol 27:1387-404. 2013
  8. doi request reprint [Design and validation of a questionnaire to measure treatment satisfaction in patients with moderate-to-severe psoriasis: the NEODERMA study]
    M Ribera
    Servicio de Dermatologia, Hospital Universitari de Sabadell, Corporacio Parc Tauli, Sabadell, Barcelona, Espana
    Actas Dermosifiliogr 102:28-38. 2011
  9. doi request reprint Spanish evidence-based guidelines on the treatment of psoriasis with biologic agents, 2013. Part 1: on efficacy and choice of treatment
    L Puig
    Servicio de Dermatologia, Hospital de la Santa Creu i Sant Pau, Universitat Autonoma de Barcelona, Barcelona, Spain Electronic address
    Actas Dermosifiliogr 104:694-709. 2013
  10. doi request reprint IL28B genetic variation and hepatitis C virus-specific CD4(+) T-cell responses in anti-HCV-positive blood donors
    M Bes
    Transfusion Safety Laboratory, Banc de Sang i Teixits, Servei Català de la Salut, Barcelona, Spain
    J Viral Hepat 19:867-71. 2012

Detail Information

Publications41

  1. doi request reprint Validation of the Spanish Acne Severity Scale (Escala de Gravedad del Acné Española--EGAE)
    Lluis Puig
    Department of Dermatology, Hospital de Sant Pau, C Sant Antoni Maria Claret, 167, 08025 Barcelona, Spain
    Eur J Dermatol 23:233-40. 2013
    ..Several acne grading systems have been described, but consensus is lacking on which shows superiority. A standardized system would facilitate therapeutic decisions and the analysis of clinical trial data...
  2. ncbi request reprint [Which patient is a candidate for treatment with efalizumab and why?]
    L Puig
    Servicio de Dermatologia, Hospital de la Santa Creu i Sant Pau, Barcelona, Espana
    Actas Dermosifiliogr 99:51-61. 2008
    ....
  3. ncbi request reprint [Infliximab: patients selection]
    L Puig
    Servicio de Dermatologia, Hospital de Santa Creu i Sant Pau, Barcelona, Espana
    Actas Dermosifiliogr 99:23-9. 2008
    ....
  4. ncbi request reprint [Efficacy of treatment with infliximab in patients with moderate-severe psoriasis and high needs of therapy. A retrospective study of 43 patients]
    L Puig
    Servicio de Dermatologia, Hospital de Santa Creu i Sant Pau, Barcelona, Espana
    Actas Dermosifiliogr 99:30-5. 2008
    ..Much of the information on efficacy and safety of infliximab comes from clinical trials, but reports on clinical practice with patients with high therapeutic needs, for whom infliximab is approved according to the EMEA label, are scarce...
  5. doi request reprint [Narrowband UV-B, monochromatic excimer laser, and photodynamic therapy in psoriasis: a consensus statement of the Spanish Psoriasis Group]
    J M Carrascosa
    Servicio de Dermatologia, Hospital Universitari Germans Trias i Pujol, Universitat Autonoma de Barcelona, Espana
    Actas Dermosifiliogr 102:175-86. 2011
    ..We discuss the efficacy and safety of phototherapy as well as treatment regimens, combination therapy, and clinical considerations relating to the characteristics of the patient or the disease...
  6. ncbi request reprint [Consensus document on the evaluation and treatment of moderate-to-severe psoriasis. Spanish psoriasis group of the Spanish Academy of Dermatology and Venereology]
    L Puig
    Servicio de Dermatologia, Hospital de la Santa Creu i Sant Pau Barcelona, Espana
    Actas Dermosifiliogr 100:277-86. 2009
    ..The present document reflects the consensus of the Spanish Psoriasis Group on these different issues in the management of moderate-to-severe psoriasis...
  7. doi request reprint Clinical practice guideline for an integrated approach to comorbidity in patients with psoriasis
    E Dauden
    Dermatology Department, IIS Princesa, Hospital Universitario La Princesa, Madrid, SpainRheumatology Department, IIS Princesa, Hospital Universitario La Princesa, Madrid, SpainInternal Medicine Department, IIS Princesa, Hospital Universitario La Princesa, Madrid, SpainDepartment of Psychiatry, Hospital Miguel Servet, Zaragoza, SpainAdvanced Techniques in Health Services Research TAISS, Madrid, SpainDermatology Department, Hospital Germans Trias i Pujol, Badalona, SpainDermatology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, SpainDermatology Department, Hospital General, Valencia, Spain
    J Eur Acad Dermatol Venereol 27:1387-404. 2013
    ..Such an integrated approach also serves to ensure that the drugs used to treat associated diseases do not interfere with the management of psoriasis, and vice versa...
  8. doi request reprint [Design and validation of a questionnaire to measure treatment satisfaction in patients with moderate-to-severe psoriasis: the NEODERMA study]
    M Ribera
    Servicio de Dermatologia, Hospital Universitari de Sabadell, Corporacio Parc Tauli, Sabadell, Barcelona, Espana
    Actas Dermosifiliogr 102:28-38. 2011
    ..the aim of this study was to design and assess the validity, reliability, and sensitivity to change of the Spanish Satisfaction With Treatment of Psoriasis Questionnaire (SSTPQ) for use in patients with moderate-to-severe psoriasis...
  9. doi request reprint Spanish evidence-based guidelines on the treatment of psoriasis with biologic agents, 2013. Part 1: on efficacy and choice of treatment
    L Puig
    Servicio de Dermatologia, Hospital de la Santa Creu i Sant Pau, Universitat Autonoma de Barcelona, Barcelona, Spain Electronic address
    Actas Dermosifiliogr 104:694-709. 2013
    ..This update of the clinical practice guidelines issued by the Spanish Academy of Dermatology and Venereology (AEDV) on biologic therapy for psoriasis incorporates information from the most recent publications on this topic. ..
  10. doi request reprint IL28B genetic variation and hepatitis C virus-specific CD4(+) T-cell responses in anti-HCV-positive blood donors
    M Bes
    Transfusion Safety Laboratory, Banc de Sang i Teixits, Servei Català de la Salut, Barcelona, Spain
    J Viral Hepat 19:867-71. 2012
    ..Although the protective rs12979860 IL28B CC genotype is associated with spontaneous HCV clearance, stronger CD4(+) T-cell responses towards NS3 were only evident among those with non-CC haplotypes...
  11. ncbi request reprint [Treatment of moderate-severe psoriasis with etanercept in patients with chronic human immunodeficiency virus infection]
    D Barco
    Servicio de Dermatologia, Hospital de la Santa Creu i Sant Pau, Barcelona, Espana
    Actas Dermosifiliogr 101:77-81. 2010
    ..There were no adverse events or changes in CD4+ lymphocyte and viral load all along the treatment...
  12. doi request reprint Safety and effectiveness of ustekinumab and antitumour necrosis factor therapy in patients with psoriasis and chronic viral hepatitis B or C: a retrospective, multicentre study in a clinical setting
    R Navarro
    Department of Dermatology, Hospital Universitario de la Princesa, Madrid, Spain
    Br J Dermatol 168:609-16. 2013
    ..Both the safety and efficacy of biologic therapy may be affected in the presence of highly prevalent chronic viral hepatitis...
  13. doi request reprint [Integrated approach to comorbidity in patients with psoriasis.Working Group on Psoriasis-associated Comorbidities]
    E Dauden
    Servicio de Dermatologia, IIS Princesa, Hospital Universitario La Princesa, Madrid, Espana
    Actas Dermosifiliogr 103:1-64. 2012
    ..The statements concerning the impact on psoriasis of the associated diseases and their treatment are based on the review of the literature...
  14. ncbi request reprint [Spanish evidence-based guidelines on the treatment of moderate-to-severe psoriasis with biologic agents]
    L Puig
    Servicio de Dermatologia, Hospital de la Santa Creu i Sant Pau, Barcelona, Espana
    Actas Dermosifiliogr 100:386-413. 2009
    ....
  15. doi request reprint Efalizumab treatment of psoriasis vulgaris: a cohort study in outpatient clinical practice
    L Puig
    Department of Dermatology, Hospital de la Santa Creu i Sant Pau, Barcelona, Catalonia, Spain
    Clin Exp Dermatol 34:469-75. 2009
    ....
  16. doi request reprint Adherence and patient satisfaction with topical treatment in psoriasis, and the use, and organoleptic properties of such treatments: a Delphi study with an expert panel and members of the Psoriasis Group of the Spanish Academy of Dermatology and Venereolo
    L Puig
    Servicio de Dermatologia, Hospital de la Santa Creu i Sant Pau, Universitat Autonoma de Barcelona, Barcelona, Spain
    Actas Dermosifiliogr 104:488-96. 2013
    ..Topical therapy is key to the successful management of psoriasis, and patient adherence to treatment contributes to its effectiveness in the long-term...
  17. ncbi request reprint [Psoriatic arthritis: what the dermatologist needs to know, Part 2]
    A Lopez-Ferrer
    Servicio de Dermatologia, Hospital de la Santa Creu i Sant Pau, Barcelona, Espana
    Actas Dermosifiliogr 101:742-8. 2010
    ..Emerging strategies for treating this condition and improving prognosis are examined...
  18. doi request reprint Obesity and psoriasis: body weight and body mass index influence the response to biological treatment
    L Puig
    Department of Dermatology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
    J Eur Acad Dermatol Venereol 25:1007-11. 2011
    ..Infliximab response appears to be independent of body mass index. Possible weight-based dose adjustments and the impact of treatment on body weight changes also require additional study...
  19. doi request reprint Efficacy of ustekinumab in refractory palmoplantar pustular psoriasis
    C Morales-Múnera
    Hospital de la Santa Creu i Sant Pau, Universitat Autonoma de Barcelona, Sant Antoni Maria Claret 167, 08025, Barcelona, Catalonia, Spain
    Br J Dermatol 168:820-4. 2013
    ..Palmoplantar pustulosis (PPP) is characterized by sterile pustules with hyperkeratosis, erythema, scaling and fissuring on the palms and soles. PPP can present alone, or in association with palmoplantar pustular psoriasis (PPPP)...
  20. ncbi request reprint Masson's intravascular papillary endothelial hyperplasia mimicking Stewart-Treves syndrome: report of a case
    J Romani
    Department of Dermatology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
    Cutis 59:148-50. 1997
    ..We believe it represents a peculiar morphologic pattern of endothelium proliferation secondary to venous stasis and thrombosis due to lymphedema...
  21. doi request reprint Reversal of nonstructural protein 3-specific CD4(+) T cell dysfunction in patients with persistent hepatitis C virus infection
    M Bes
    Transfusion Safety Laboratory, Banc de Sang i Teixits, Servei Català de la Salut, Barcelona, Spain
    J Viral Hepat 19:283-94. 2012
    ..Hence, NS3-specific CD4(+) T cell response can be rescued in most chronic HCV patients by in vitro expansion in the absence of HCV-specific antigen. These results might provide a rationale for adoptive immunotherapy...
  22. doi request reprint Treatment of severe psoriasis
    L Puig
    Department of Dermatology, Hospital de Santa Creu i Sant Pau, Universitat Autonoma de Barcelona, Barcelona, Spain
    J Eur Acad Dermatol Venereol 26:17-8. 2012
    ....
  23. ncbi request reprint Differential expression of c-Met in Kaposi's sarcoma according to progression stage and HIV infection status
    L Puig
    Department of Dermatology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
    J Cutan Pathol 26:227-31. 1999
    ..The staining intensity of c-Met was stronger in tumors than in plaques. When only plaques were taken into consideration, the mean staining score was nearly twice as high in C-KS as in AIDS-KS...
  24. doi request reprint Cardiovascular risk and psoriasis: the role of biologic therapy
    L Puig
    Servicio de Dermatologia, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
    Actas Dermosifiliogr 103:853-62. 2012
    ..We review the current scientific evidence on this topic...
  25. ncbi request reprint Review of 26 cases of classical pyoderma gangrenosum: clinical and therapeutic features
    D Vidal
    Dermatology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
    J Dermatolog Treat 15:146-52. 2004
    ..Classical pyoderma gangrenosum (CPG) is an uncommon, idiopathic, neutrophilic skin disease, generally associated with other skin conditions and systemic diseases, and with several treatment options...
  26. doi request reprint Ustekinumab in clinical practice: response depends on dose and previous treatment
    V Ruiz Salas
    Department of Dermatology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
    J Eur Acad Dermatol Venereol 26:508-13. 2012
    ....
  27. ncbi request reprint Adams-Oliver syndrome with unusual central nervous system alterations
    J Romani
    Department of Dermatology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
    Pediatr Dermatol 15:48-50. 1998
    ..We report an infant with Adams-Oliver syndrome associated with intracranial calcifications in whom no evidence of intrauterine infection could be demonstrated...
  28. ncbi request reprint Adverse cutaneous reactions to anakinra in patients with rheumatoid arthritis: clinicopathological study of five patients
    A T Vila
    Department of Dermatology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
    Br J Dermatol 153:417-23. 2005
    ..Anakinra, a recombinant human form of interleukin-1 receptor antagonist, is used to treat patients with active rheumatoid arthritis (RA)...
  29. ncbi request reprint [Psoriatic arthritis: what the dermatologist needs to know, part 1]
    A Lopez-Ferrer
    Servicio de Dermatologia, Hospital de la Santa Creu i Sant Pau, Barcelona, Espana
    Actas Dermosifiliogr 101:578-84. 2010
    ..It examines the epidemiology, pathogenesis, and manifestations of psoriatic arthritis, as well as the complementary tests and diagnostic tools the dermatologist should be aware of in order to make the correct diagnosis...
  30. doi request reprint Impact of active and stable psoriasis on health-related quality of life: the PSO-LIFE study
    E Dauden
    Servicio de Dermatologia, Hospital Universitario de la Princesa, Madrid, Spain
    Actas Dermosifiliogr 104:685-93. 2013
    ..The aim of this study was to assess the impact of psoriasis on health-related quality of life (HRQOL) using different questionnaires...
  31. doi request reprint Adalimumab for the treatment of psoriasis in real life: a retrospective cohort of 119 patients at a single Spanish centre
    A Lopez-Ferrer
    Department of Dermatology, Hospital de la Santa Creu i Sant Pau, Universitat Autonoma de Barcelona, Sant Antoni Maria Claret 167, 08025, Barcelona, Catalonia, Spain
    Br J Dermatol 169:1141-7. 2013
    ..Patients with moderate-to-severe psoriasis treated with adalimumab in daily clinical practice are different from those in clinical trials, and outcomes may differ in different geographical settings...
  32. ncbi request reprint Pityriasis lichenoides in children: clinicopathologic review of 22 patients
    J Romani
    Department of Dermatology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
    Pediatr Dermatol 15:1-6. 1998
    ....
  33. ncbi request reprint Erythema gyratum atrophicans transiens neonatale: a variant of cutaneous neonatal lupus erythematosus
    L Puig
    Department of Dermatology, Hospital de Sta. Creu i Sant Pau, Barcelona, Spain
    Pediatr Dermatol 5:112-6. 1988
    ....
  34. doi request reprint Expert report on psoriasis: Spanish dermatologists' opinions on the use of biologic agents to manage moderate to severe psoriasis in adults
    L Puig
    Servicio de Dermatologia, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
    Actas Dermosifiliogr 104:400-8. 2013
    ..Although national guidelines on biologic agents for treating moderate to severe psoriasis in adults have been published in several countries, increased knowledge on the practical aspects of their implementation is required...
  35. ncbi request reprint Therapy of paraneoplastic pemphigus with Rituximab: a case report and review of literature
    Ma Barnadas
    Department of Dermatology, Hospital Sta Creu i St Pau, Barcelona, Spain
    J Eur Acad Dermatol Venereol 20:69-74. 2006
    ..The patient died 2 years and 7 months after the onset of PNP. Rituximab may be useful for PNP therapy, but further studies are necessary to confirm this hypothesis...
  36. ncbi request reprint [Treatment of scalp psoriasis: review of the evidence and Delphi consensus of the Psoriasis Group of the Spanish Academy of Dermatology and Venereology]
    L Puig
    Servicio de Dermatologia, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
    Actas Dermosifiliogr 101:827-46. 2010
    ..The only formulations that have been studied in the long-term treatment of scalp psoriasis are a combination of calcipotriol and betamethasone in gel and calcipotriol alone in solution...
  37. ncbi request reprint Interferon and ribavirin combination therapy for chronic hepatitis C in human immunodeficiency virus-infected patients with congenital coagulation disorders
    S Sauleda
    , , Hospital Universtari Vall d'Hebron, , Barcelona, Spain
    Hepatology 34:1035-40. 2001
    ....
  38. ncbi request reprint Topical tacrolimus 0.1% ointment (protopic) reverses nickel contact dermatitis elicited by allergen challenge to a similar degree to mometasone furoate 0.1% with greater suppression of late erythema
    A Alomar
    Department of Dermatology, Hospital Santa Creu i Sant Pau, Sant Antoni Maria Claret 167, 08025 Barcelona, Spain
    Contact Dermatitis 49:185-8. 2003
    ..5). This method might provide useful means to compare different concentrations and/or presentations of tacrolimus or other calcineurin inhibitors and topical anti-inflammatory agents...
  39. ncbi request reprint Thrombotic thrombocytopenic purpura and pregnancy: a review of ten cases
    M Castella
    Centre de Transfusió i Banc de Teixits Unitat de Badalona, Barcelona, Spain
    Vox Sang 87:287-90. 2004
    ..A series of women with pregnancy-associated thrombotic thrombocytopenic purpura, is presented. This study will focus on the relationship between thrombotic thrombocytopenic purpura and pregnancy and on maternal and neonatal outcomes...
  40. ncbi request reprint Influence of von Willebrand factor on the reactivity of human factor VIII inhibitors with factor VIII
    M Gensana
    Research and Development Area, Instituto Grifols, SA, Barcelona, Spain
    Haemophilia 7:369-74. 2001
    ..We conclude that there might be a protective role of vWF (at least in vitro) against FVIII inhibitors with A2 and LC subunit specificity...
  41. ncbi request reprint Calcinosis cutis following calcium chloride electrode paste application for auditory-brainstem evoked potentials recording
    L Puig
    Department of Dermatology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
    Pediatr Dermatol 15:27-30. 1998
    ..In both patients small stony pellets were extruded during the healing process, which took 11 and 9 weeks, respectively, and left no scars...